Low Serum ZAG Levels Correlate With Determinants of the Metabolic Syndrome in Chinese Subjects

Expression and Function of Zinc-α2-Glycoprotein

(2019) Xin Wei et al.   Neuroscience Bulletin

Serum Zinc-α2-Glycoprotein Levels Were Decreased in Patients With Premature Coronary Artery Disease

(2019) Meijuan Liu et al.   Frontiers in Endocrinology

Role of Zinc in Zinc-α2-Glycoprotein Metabolism in Obesity: a Review of Literature

(2019) Juliana Soares Severo et al.   BIOLOGICAL TRACE ELEMENT RESEARCH

Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome

(2019) C. Ronald Kahn et al.   JOURNAL OF CLINICAL INVESTIGATION

Childhood retinol-binding protein 4 (RBP4) levels predicting the 10-year risk of insulin resistance and metabolic syndrome: the BCAMS study

(2018) Ge Li et al.   Cardiovascular Diabetology

Zinc alpha2 glycoprotein protects against obesity-induced hepatic steatosis

(2018) Xin-Hua Xiao et al.   INTERNATIONAL JOURNAL OF OBESITY

Zinc-α2-Glycoprotein Is Associated with Obesity in Chinese People and HFD-Induced Obese Mice

(2018) Meijuan Liu et al.   Frontiers in Physiology

Dynamics of adipose tissue turnover in human metabolic health and disease

(2018) Ursula White et al.   DIABETOLOGIA

Circulating zinc-α2-glycoprotein levels are low in newly diagnosed patients with metabolic syndrome and correlate with adiponectin

(2017) Lu Lei et al.   Nutrition & Metabolism

Leptin-adiponectin imbalance as a marker of metabolic syndrome among Chinese children and adolescents: The BCAMS study

(2017) Ge Li et al.   PLoS One

Circulating Zinc-α2-glycoprotein levels and Insulin Resistance in Polycystic Ovary Syndrome

(2016) Yerui Lai et al.   Scientific Reports

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Increases Circulating Zinc-Α2-Glycoprotein Levels in Patients with Type 2 Diabetes

(2016) Xin Liao et al.   Scientific Reports

Tissue alkaline phosphatase is involved in lipid metabolism and gene expression and secretion of adipokines in adipocytes

(2015) Claudia Hernández-Mosqueira et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Plasma zinc α2-glycoprotein levels are elevated in smokers and correlated with metabolic syndrome

(2015) Jaw-Shiun Tsai et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Effects of sitagliptin on circulating zinc-α2-glycoprotein levels in newly diagnosed type 2 diabetes patients: a randomized trial

(2015) Mingyuan Tian et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Zinc-α2-Glycoprotein Modulates AKT-Dependent Insulin Signaling in Human Adipocytes by Activation of the PP2A Phosphatase

(2015) Victòria Ceperuelo-Mallafré et al.   PLoS One

Significance of serum Zn-α2-glycoprotein for the regulation of blood pressure

(2014) Souichi Kurita et al.   HYPERTENSION RESEARCH

Zinc-α2-Glycoprotein Expression in Adipose Tissue of Obese Postmenopausal Women before and after Weight Loss and Exercise + Weight Loss

(2014) Shealinna Ge et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Subcutaneous adipose tissue zinc-α2-glycoprotein is associated with adipose tissue and whole-body insulin sensitivity

(2014) Miroslav Balaz et al.   Obesity

Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies

(2014) S. O'Neill et al.   Obesity Reviews

Zinc- 2-Glycoprotein Is Associated With Insulin Resistance in Humans and Is Regulated by Hyperglycemia, Hyperinsulinemia, or Liraglutide Administration: Cross-sectional and interventional studies in normal subjects, insulin-resistant subjects, and subjects with newly diagnosed diabetes

(2012) M. Yang et al.   DIABETES CARE

Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER-medicare database

(2011) Tania M. Welzel et al.   HEPATOLOGY

Studies on the antiobesity effect of zinc-α2-glycoprotein in the ob/ob mouse

(2010) S T Russell et al.   INTERNATIONAL JOURNAL OF OBESITY

Zinc-α2-glycoprotein: an adipokine modulator of body fat mass?

(2010) C Bing et al.   INTERNATIONAL JOURNAL OF OBESITY

Macrophage-secreted factors inhibit ZAG expression and secretion by human adipocytes

(2010) D. Gao et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Cigarette Smoking Induces Overexpression of a Fat-Depleting Gene AZGP1 in the Human

(2009) Holly Vanni et al.   CHEST

The adipokine zinc-α2-glycoprotein (ZAG) is downregulated with fat mass expansion in obesity

(2009) T. Mracek et al.   CLINICAL ENDOCRINOLOGY

Zinc-α2-glycoprotein is involved in regulation of body weight through inhibition of lipogenic enzymes in adipose tissue

(2009) F-Y Gong et al.   INTERNATIONAL JOURNAL OF OBESITY

Serum Zinc-α2-Glycoprotein Correlates with Adiposity, Triglycerides, and the Key Components of the Metabolic Syndrome in Chinese Subjects

(2009) Dennis C. Y. Yeung et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Lower Zinc-α2-Glycoprotein Production by Adipose Tissue and Liver in Obese Patients Unrelated to Insulin Resistance

(2009) David M. Selva et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Downregulation of zinc-α2-glycoprotein in adipose tissue and liver of obese ob/ob mice and by tumour necrosis factor-α in adipocytes

(2009) T Mracek et al.   JOURNAL OF ENDOCRINOLOGY

ZAG, a lipid mobilizing adipokine, is downregulated in human obesity

(2009) M. P. Marrades et al.   JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY

Abdominal Obesity and the Metabolic Syndrome: Contribution to Global Cardiometabolic Risk

(2008) Jean-Pierre Després et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Metabolic Syndrome and Incident Diabetes: Current state of the evidence

(2008) E. S. Ford et al.   DIABETES CARE

Determination of serum zinc-alpha-2-glycoprotein in patients with metabolic syndrome by a new ELISA

(2007) D. Stejskal et al.   CLINICAL BIOCHEMISTRY